Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

76.24 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
31 32 Next >
FDA Warns Cybersecurity Vulnerability For Illumina Sequencers
The FDA issued a letter noting that nearly the 
Via Benzinga
3 Telemedicine Stocks to Watch as Healthcare Goes Digital
The telemedicine stocks discussed in the article offer incredible upside ahead in the fast-evolving telehealth sector 
Via InvestorPlace
Realtimecampaign.com Discusses Some of the Many Benefits of Genotyping
Via Get News
Here's How Much You Would Have Made Owning Illumina Stock In The Last 10 Years
Via Benzinga
Baird Maintains Neutral Rating for Illumina: Here's What You Need To Know
Via Benzinga
Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings
Via Benzinga
Illumina Narrowly Squeaks Out First-Quarter Beat As Grail Battle Continues
The company is fighting both regulators and its own shareholders to retain Grail. 
Via Investor's Business Daily
This Is What Whales Are Betting On Illumina
Via Benzinga
A Preview Of Illumina's Earnings
Via Benzinga
Looking At Illumina's Recent Unusual Options Activity
Via Benzinga
Profit from the Artificial Intelligence Boom with These 7 AI ETFs
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at... 
Via Talk Markets
Here's Why You Shouldn't Buy the Dip With Illumina Stock
There aren't many factors driving its growth at the moment. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
What Does Illumina's Debt Look Like?
Via Benzinga
Is There Any Hope for Illumina Stock?
Being in trouble with regulators in two major markets sure won't help anything. 
Via The Motley Fool
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global... 
Via Benzinga
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire. 
Via InvestorPlace
Illumina Unusual Options Activity
Via Benzinga
FTC Orders Illumina To Divest Grail, Mounts Pressure On Company Amid Proxy Fight With Icahn
Via Benzinga
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell. 
Via Investor's Business Daily
A Look Into Illumina's Debt
Via Benzinga
(ILMN) - Analyzing Illumina's Short Interest
Via Benzinga
7 Stocks Gearing Up for a Major Breakout
With the stock market gearing up for a major breakout, there are many potential breakout stocks at this point. 
Via InvestorPlace
What's The Similiarity Between Disney And Illumina? Billionaire Activist Investor Wanted Retired CEO To Come Back
After launching a proxy battle against Illumina Inc (NASDAQ: ILMN), activist investor Carl Icahn has clarified that he wants management change with former CEO Jay Flatley to come back and Grail... 
Via Benzinga
DNA Data Storage Alliance Announces Board Appointments
From DNA Data Storage Alliance
Via Business Wire
Next Generation Sequencing Technology Market 2023 Innovation, Application, Future Trends, Outlook by Type, Application and Business Opportunities to 2030
Next Generation Sequencing Technology Market Growth and Outlook 2023-2030 SWOT Analysis by Key Players – Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life... 
Via SBWire
Individual Stock Picks As The Fed Tightens Financial Conditions Further Despite Banking Stress
We provide free access to the episode's chart pack, including all of the data discussed. 
Via Benzinga
Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories
Reuters 
Via Benzinga
Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.